US Executive Officer Management Changes SEC — July 28, 2026

28-07-2026

Centene Corporation reported Q2 2026 GAAP diluted EPS of $2.19 and adjusted diluted EPS of $2.51, a significant turnaround from a GAAP loss of $(0.51) per share in Q2 2025. Total revenues rose 4% to $53.6 billion, driven by premium yield and PDP membership growth, while the consolidated HBR improved to 89.6% from 93.0%. However, total at-risk membership declined 7.6% year-over-year to 25.9 million, with Commercial membership falling 37% and Medicaid down 5.5%, partially offset by PDP growth. The company raised its full-year 2026 adjusted diluted EPS guidance to greater than $4.80.

• · Commercial HBR improved to 79.2% in Q2 2026, demonstrating significant year-over-year improvement in profitability.
• · Medicare segment HBR of 89.5% included fundamental outperformance in both Medicare Advantage and PDP.
• · Medicaid HBR of 93.9% was in-line with expectations.
• · Guidance increase includes approximately $0.50 of non-recurring items in Medicare and Commercial segments.
• · The company repurchased $260 million of senior notes due 2027 and 2028 during Q2 2026.
• · No borrowings on the $4.0 billion Revolving Credit Facility at quarter end.
• · Days in claims payable (DCP) was 47 days, down one day from Q1 2026 due to timing of state directed payments.
• · Full year 2026 GAAP diluted EPS guidance raised to greater than $3.11; adjusted diluted EPS guidance raised to greater than $4.80.
• · Full year 2026 total revenues guidance raised by $6.0 billion to a range of $193.5B to $197.5B.
• · Full year 2026 premium and service revenues guidance raised by $2.0 billion to a range of $173.0B to $177.0B.
• · Full year 2026 HBR guidance range is 90.5% to 91.3%.
• · Full year 2026 adjusted SG&A expense ratio guidance range is 6.9% to 7.5%.
• · Full year 2026 adjusted effective tax rate guidance range is 25.5% to 26.5%.
• · Full year 2026 diluted shares outstanding guidance range is 497 million to 500 million.
• · Adjusted net earnings for Q2 2026 were $1,248 million, compared to an adjusted net loss of $(79) million in Q2 2025.
• · GAAP net earnings for Q2 2026 were $1,091 million, compared to a GAAP net loss of $(253) million in Q2 2025.
• · Enterprise optimization costs for Q2 2026 were $37 million pre-tax.
• · Severance costs due to enterprise optimization and contract exits for Q2 2026 were $15 million pre-tax.
• · Net gain on debt extinguishment for Q2 2026 was $6 million pre-tax.
• · Amortization of acquired intangible assets for Q2 2026 was $161 million pre-tax.
• · The company operated MMPs through December 31, 2025; in 2026 these members are included in Medicare due to CMS transition to D-SNP based integration.

28-07-2026

Hormel Foods announced the appointment of John F. Ghingo, currently President, as President and CEO effective October 26, 2026, succeeding Interim CEO Jeffrey M. Ettinger. Ghingo's annual base salary will increase from $730,000 to $1.28 million, with a short-term incentive target of 150% of salary and a long-term incentive target of $6.8 million. Ettinger will remain on the Board.

• · Ghingo previously served as CEO of Whisps Acquisition Corporation from January 2022 to August 2024.
• · Ghingo holds an undergraduate degree in marketing from the University of Notre Dame and an MBA from NYU Stern.
• · Ettinger's interim CEO service ends October 25, 2026, per a June 20, 2025 Employment Agreement.
• · Ghingo will be eligible for benefits under the Executive Severance Plan with a severance factor of 2x.
• · Long-term incentive grants are anticipated to start in December 2026.

28-07-2026

Conagra Brands announced that EVP and COO Thomas McGough will retire by September 4, 2026, and the company will eliminate the COO position upon his departure. This represents a structural change in the executive leadership team but does not include any financial metrics or performance data.

• · The COO position will be eliminated after Mr. McGough's retirement.
• · Mr. McGough's retirement date is no later than September 4, 2026.
• · The filing was signed by Carey Bartell, EVP, General Counsel and Corporate Secretary.

28-07-2026

Adeia Inc. announced amendments to severance agreements for its CFO, CRO, and Chief Legal Officer, approved on July 22, 2026. The changes enhance equity acceleration provisions for qualifying terminations, including performance-based awards, but do not alter base severance terms. This is a routine compensation governance update with no immediate financial impact.

• · Amended agreements cover Qualifying Termination and CIC Qualifying Termination scenarios.
• · For Qualifying Termination, executives get accelerated vesting of equity awards scheduled to vest within 12 months post-termination.
• · For CIC Qualifying Termination, all outstanding equity awards accelerate immediately upon later of termination or change in control.
• · Performance-based awards vest based on actual achievement for completed fiscal years and the greater of target or actual for other goals.
• · The form of amended agreement will be filed with the Q2 2026 10-Q.

28-07-2026

CNH Industrial N.V. announced the retirements of Chief Technology Officer Jay Schroeder (effective January 1, 2027) and Agriculture Chief Commercial Officer Stefano Pampalone (effective September 1, 2026), both after decades of service. Eric Shuman will succeed Schroeder as CTO, while Chun Woytera, Carlo Materazzo, and Markus Müller will assume expanded global leadership roles upon Pampalone's retirement. No financial metrics or performance data were disclosed in this filing.

• · Effective dates: Schroeder retires January 1, 2027; Pampalone retires September 1, 2026.
• · Eric Shuman has been with the company for over 25 years, most recently as VP, Precision Technology Product Management since June 2025.
• · No family relationships or reportable transactions involving Shuman per Regulation S-K Item 404(a).
• · Compensatory arrangements for Shuman’s new role are not yet finalized.
• · Both retiring executives will remain in advisory capacities for transition support.
• · Three executives assume expanded roles upon Pampalone’s retirement: Woytera (Chief Product & Sustainability Officer), Materazzo (Chief Manufacturing & Quality Officer), Müller (President, EMEA and Parts & Service).

28-07-2026

Unusual Machines, Inc. granted CEO Dr. Allan Evans warrants to purchase 5,000,000 shares at $25.00, vesting upon stock price targets from $25 to $100, in exchange for waiving all cash compensation after Dec 31, 2026. The company also granted stock options to three other executives: President Andrew Camden (525,000 options), CFO Brian Hoff (375,000), and CRO Stacy Wright (375,000), all at $19.36 per share, vesting quarterly over three years. The warrants are subject to shareholder approval.

• · Warrant exercise price is $25.00 per share, expiring July 24, 2031.
• · Warrants vest in five equal tranches of 1,000,000 shares each upon stock price targets of $25, $40, $60, $80, and $100.
• · Stock options for executives are exercisable at $19.36 per share and vest in 12 equal quarterly installments over three years.
• · CEO Dr. Evans agreed to waive all cash compensation after December 31, 2026 in consideration for the warrant grant.
• · The warrant grant is subject to shareholder approval.

28-07-2026

Kennametal Inc. announced a board leadership transition, with Joseph Alvarado appointed as incoming Chairman effective October 28, 2026, succeeding William Lambert who will retire on October 27, 2026. The change follows Lambert's tenure since 2016 and as Chairman since 2023, during which he guided the company through transformation. No financial or operational results were disclosed, and the filing contains no period-over-period comparisons or negative metrics.

• · Lambert joined the Board in 2016 and served as Chairman since 2023.
• · Alvarado has served on the Board since 2018 and was chair of the Nominating/Corporate Governance Committee since 2023.
• · Alvarado is the retired Chairman, President and CEO of Commercial Metals Company and holds an MBA from Cornell University and a BA in Economics from the University of Notre Dame.
• · The company has approximately 8,100 employees and generated $2 billion in revenues in fiscal 2025.

28-07-2026

On July 27, 2026, director William R. McDermott resigned from the board of Zoom Communications, Inc., effective immediately. The resignation was not due to any disagreement with the company regarding its operations, policies, or practices. No financial metrics or performance data were disclosed in this filing.

• · William R. McDermott's resignation was effective immediately on July 27, 2026.
• · The resignation was not due to any disagreements with the company on operations, policies, or practices.

28-07-2026

Carpenter Technology Corporation announced the sudden and unexpected passing of President and CEO Brian Malloy on July 24, 2026. Executive Chairman Tony Thene has been appointed by the Board to return as CEO effective immediately, a role he previously held from 2015 through June 2026. The company extended condolences to Malloy's family and highlighted his decade of contributions to operational excellence and long-term success.

• · Brian Malloy passed away suddenly and unexpectedly on Friday, July 24, 2026.
• · Tony Thene previously served as CEO from 2015 through June 2026.
• · Thene will also continue in his role as Chairman of the Board.
• · Carpenter Technology was founded in 1889 and focuses on aerospace, defense, medical, transportation, energy, and industrial markets.

28-07-2026

On July 24, 2026, Independence Power Holdings, Inc. (the Company) announced that CFO Brian Dutton will step down effective August 14, 2026 to pursue another professional opportunity. The Company stated his resignation is unrelated to financial or operating results or any disagreements with Company policies, and it has initiated an external search for a replacement.

• · CFO resignation effective August 14, 2026
• · Resignation is for another professional opportunity and not related to financial or operating results or disagreements
• · External search for replacement CFO has been initiated

28-07-2026

Adtalem Global Education Inc. (NYSE: ATGE), operating as Covista, announced the appointments of Emily C. Chiu and Leslie Storms to its Board of Directors, effective August 17, 2026. The new directors bring expertise in technology, fintech, edtech, healthcare delivery, medtech, and veterinary medicine, supporting the company's three-year growth strategy, 'Purpose at Scale.' The filing is a routine board composition update and does not include any financial results or negative performance metrics.

• · Covista is the parent company of five accredited institutions: American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
• · With the appointments, 10 of Covista's 12 directors will be independent.
• · Emily Chiu previously co-founded ventures in higher education recognized by EDUCAUSE and The Bill & Melinda Gates Foundation as a 'breakthrough model in college completion'.
• · Leslie Storms spent nearly two decades at Johnson & Johnson, holding senior leadership roles including President, U.S. Orthopedics and President, U.S. Surgery.

28-07-2026

Satellogic Inc. announced that CFO Rick Dunn will resign effective August 21, 2026, as previously disclosed. The company's search for a permanent successor is ongoing, and if no successor is appointed by the separation date, SVP and Corporate Controller Dustin Greer is expected to serve as interim CFO. The transition will be discussed on the upcoming earnings call scheduled for August 5, 2026.

• · Rick Dunn's resignation as CFO is effective August 21, 2026.
• · Dustin Greer, age 47, has served as Corporate Controller since 2022 and previously was Senior Director, FP&A and Business Insights at Trilogy International Partners.
• · No material plan, contract, or arrangement has been entered into with Mr. Greer in connection with the expected interim CFO appointment.
• · The company will discuss the transition during its earnings call on August 5, 2026.

28-07-2026

Haemonetics Corporation announced the election of Dr. Martin Madaus to its Board of Directors, effective July 24, 2026. Dr. Madaus brings over 30 years of leadership experience in diagnostics and life sciences, having served as CEO of Ortho Clinical Diagnostics and Millipore Corporation, and currently as Senior Operating Executive at The Carlyle Group. The appointment strengthens the board with deep operational, commercial, and strategic expertise, though no specific financial metrics or performance changes were disclosed.

• · Dr. Madaus currently serves as Senior Operating Executive at The Carlyle Group, advising on healthcare investments since 2019.
• · He previously led Ortho Clinical Diagnostics' turnaround after its carve-out from Johnson & Johnson.
• · He holds a Doctor of Veterinary Medicine from the University of Munich and a Ph.D. in Veterinary Medicine from the Veterinary School of Hanover in Germany.
• · Dr. Madaus serves as Chair of the Board of Repligen Corporation and as a board member of Azenta, Inc.

28-07-2026

NPK International Inc. appointed Kristen J. Pederson to its board of directors effective July 28, 2026. Ms. Pederson brings extensive public company board, strategic planning, governance, finance, and audit experience, and will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees. The appointment strengthens the board's expertise as the company executes its strategy and expands market presence.

• · Ms. Pederson holds an MBA from Harvard Business School and completed undergraduate studies at the University of California, Los Angeles.
• · She previously held senior roles at IBM and was a partner at Ernst & Young LLP and PricewaterhouseCoopers LLP.
• · She currently serves as a director of SOBR Safe, Inc. and Eagle Bancorp, Inc.

28-07-2026

Oklo Inc. announced the appointment of five executive officers effective July 27, 2026, including Alexandra Renner as Chief Product Officer, John Hanson as Chief of Staff, Vivek Narayanadas as General Counsel and Corporate Secretary, Erik Lassen as Senior Vice President of Engineering, and Michael Dixon as Vice President of Accounting and Controller (Principal Accounting Officer). All appointees are internal promotions or recent hires, with no new compensatory plans, equity awards, or material amendments to existing arrangements. The filing contains no financial data or period-over-period comparisons.

• · All five appointees have no family relationships with any director or other executive officer of the Company.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K exist for any appointee.
• · The Company did not enter into any new compensatory plan, contract, or arrangement with the appointees, nor grant any equity awards.

28-07-2026

Terrestrial Energy Inc. announced the appointment of Kathryn McCarthy to its Board of Directors, bringing decades of nuclear science and technology leadership from national laboratories. The company also set its Q2 2026 earnings release and conference call for August 11, 2026. No financial results or performance metrics were disclosed in this filing.

• · Kathryn McCarthy holds a Ph.D. in nuclear engineering from UCLA and is a member of the National Academy of Engineering and a Fellow of the American Nuclear Society.
• · McCarthy previously served as Senior Advisor at Oak Ridge National Laboratory since 2026, supporting strategic decisions in the US ITER Project and fusion research.
• · The Q2 2026 earnings call will be held on August 11, 2026, at 8:30 a.m. Eastern Time, with CEO Simon Irish and CFO Brian Thrasher participating.
• · Terrestrial Energy is targeting the early 2030s for building, licensing, and commissioning the first IMSR Plants.

28-07-2026

BARK, Inc. announced the appointment of Anya Hamill as Chief Financial Officer, effective September 8, 2026. Ms. Hamill brings over 20 years of financial leadership experience from public CPG companies and private equity-backed firms, most recently serving as CFO of Laird Superfood from 2022 to 2026. The outgoing interim CFO, Brian Dostie, will remain as Vice President, Accounting and Controller. This is a positive leadership addition, but no financial metrics or performance data were disclosed in this filing.

• · Ms. Hamill's appointment is effective September 8, 2026.
• · She previously served as CFO of Laird Superfood from 2022 to 2026.
• · She also served as CFO of Little Secrets Chocolates from 2018 to 2022.
• · Brian Dostie, who served as Interim CFO for the past year, will continue as VP, Accounting and Controller.

28-07-2026

Diodes Incorporated elected Evan Yu to its Board of Directors as an independent director, effective August 1, 2026. Yu is a former Senior Vice President of Worldwide Power Products at Diodes, having retired in January 2023, and brings deep semiconductor expertise and international experience. The appointment strengthens the board's governance and strategic oversight, with Yu qualifying as independent under Nasdaq and SEC rules.

• · Yu previously served as Senior Vice President, Worldwide Power Products at Diodes from 2008 until his retirement in January 2023.
• · Before Diodes, Yu was CEO of Commit Inc., an Asian wireless communications chipset company focused on 3G/4G technologies.
• · Yu worked at Texas Instruments for 15 years, including as Asia Vice President of the Application Specific Products (ASP) organization.
• · Yu most recently served as Chairman of the Board of Canyon Semiconductor Inc.
• · Yu studied electrical engineering at Kaohsiung Institute of Technology and earned his bachelor's degree in Electrical Engineering at Tam Kang University in Taiwan.
• · The company contact is Gurmeet Dhaliwal (P: 408-232-9003, E: Gurmeet_Dhaliwal@diodes.com).

28-07-2026

Global Asset Management Group, Inc. (KENS) announced the retirement of Director Daniel Snyder, effective July 24, 2026, and the appointment of David Marshall Nissman to the Board and Audit Committee. The company also appointed Daniel Bell and Darryl Barnes as Strategic Advisors to its Corporate Advisory Board to support growth, business planning, and shareholder communications. No financial metrics or performance data were disclosed in this filing.

• · Daniel Snyder's resignation was for personal business reasons and not due to any dispute with the company.
• · David Marshall Nissman previously served as the 19th United States Attorney for the District of the Virgin Islands.
• · Daniel Bell has over two decades of experience in transfer agency operations and capital markets.
• · Darryl Barnes served nine years in the Maryland General Assembly, including as Chief Deputy Majority Whip and Chairman of the Maryland Legislative Black Caucus.

28-07-2026

Verisk Analytics announced that EVP and CIO Nick Daffan will depart effective August 3, 2026, transitioning to a Strategic Advisor role through year-end. CTO Jeff Negrete will serve as interim CIO. Daffan's separation follows the company's Senior Executive Severance Benefits Plan.

• · Nick Daffan had more than 20 years with the company.
• · Daffan led the migration from mainframe to cloud and strengthened infrastructure for AI innovation.
• · Jeff Negrete will serve as interim CIO in addition to his current CTO role.
• · Separation terms are per Appendix A of the Verisk Senior Executive Severance Benefits Plan (disclosed April 5, 2022).

28-07-2026

HF Sinclair Corporation announced the retirement of Eric Nitcher, Executive Vice President and General Counsel, effective July 31, 2026. Mr. Nitcher will remain an employee through the end of 2026 to assist with the transition, and a successor will be named later. The retirement is not due to any disagreement with the company or its board.

• · Eric Nitcher's retirement is effective July 31, 2026.
• · He will remain an employee through the end of 2026 for an orderly transition.
• · A successor has not yet been named.

28-07-2026

Wendy's Co disclosed a one-time restricted stock unit award of $500,000 to E.J. Wunsch, President, International, approved by the Compensation and Human Capital Committee on July 22, 2026. The award is intended to maintain continuity and recognize the performance and growth of the company's International business following the appointment of Robert D. Wright as President and CEO. The award vests in equal installments over two years, subject to continued employment.

• · The award is granted under the company's 2020 Omnibus Award Plan.
• · The grant date is effective August 11, 2026.
• · Vesting occurs in substantially equal installments on each of the first two anniversaries of the grant date.
• · The award is subject to Mr. Wunsch's continued employment on the applicable vesting dates.

28-07-2026

Valmont Industries announced that Mogens C. Bay will retire from the Board of Directors at the end of fiscal year 2026 (December 26, 2026). Catherine J. Paglia, currently Vice Chair of the Board and Lead Independent Director, will succeed Mr. Bay as Board Chair upon his retirement. The filing contains no financial data or performance metrics.

• · Retirement effective date: December 26, 2026 (end of fiscal year).
• · Succession is internal: Catherine J. Paglia, already Vice Chair and Lead Independent Director, will become Board Chair.

28-07-2026

Bicara Therapeutics announced the appointments of Jeremy Bender, Ph.D., MBA and Christy Oliger to its Board of Directors, while Kiran Mazumdar-Shaw retired from the board. Dr. Bender brings over 20 years of biotech experience, having led Day One Biopharmaceuticals through its ~$2.5B acquisition by Servier, and Ms. Oliger brings 30+ years of commercial experience, including leading Genentech's oncology unit with $13B+ in U.S. revenue. The changes strengthen the board as Bicara advances its lead candidate ficerafusp alfa toward a registration-enabling study, though the company remains a clinical-stage entity with no approved products and faces significant regulatory and financial risks.

• · Dr. Bender served as CEO of Day One Biopharmaceuticals from September 2020 to April 2026, leading the company through its acquisition by Servier for approximately $2.5B.
• · Ms. Oliger managed a portfolio of 15 products at Genentech, contributing over $13B in U.S. revenue, and led an organization of more than 800 people.
• · Kiran Mazumdar-Shaw, a founding board member, retired; she provided initial seed capital and strategic guidance to Bicara.
• · Bicara's lead candidate ficerafusp alfa is a bifunctional EGFR-directed monoclonal antibody bound to a TGF-β ligand trap, being developed for head and neck squamous cell carcinoma and other solid tumors.
• · The company remains clinical-stage with no approved products, and forward-looking statements highlight risks including regulatory approval, financial needs, and competitive landscape.

28-07-2026

ZipRecruiter announced the appointment of Carmen Chan as Chief Financial Officer, effective August 17, 2026. Chan, a veteran finance leader from Barclays, Noom, and Goldman Sachs, will oversee Accounting and Finance, replacing Dave Travers who will continue as President. The filing contains no financial results or performance metrics, so no period-over-period comparisons are available.

• · Carmen Chan was named to American Banker's Most Powerful Women in Banking NEXT 2025 list.
• · Chan previously served as Head of Revenue and Business Development at theSkimm.
• · Chan held investment banking roles at UBS in London and Sydney earlier in her career.
• · ZipRecruiter has been the #1 rated job search app on iOS & Android for the past nine years (January 2017 to January 2026).
• · ZipRecruiter is rated the #1 job site by G2 based on satisfaction ratings in North America as of January 12, 2026.

28-07-2026

Andrew Winn has resigned as Chief Financial Officer of TransparentBusiness, Inc. (Unicoin Inc.) effective August 4, 2026, citing personal reasons. The resignation was disclosed via an 8-K filing on July 28, 2026. The company has not yet announced a successor or interim CFO.

• · Resignation effective end of business on August 4, 2026.
• · CFO resigning for personal reasons.
• · No successor or interim CFO has been announced.
• · Filing includes Exhibit 99.1 with the resignation letter.